Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... the safety and efficacy of udenafil, an orally administered selective inhibitor of phosphodiesterase versus placebo. The trials will be conducted in 80 sites in the U.S. and will enroll ...
2009 NOV 16 ... Caffeine, Cardiology, Cardiovascular, Central Nervous System Stimulant, Metabolism, Phosphodiesterase Inhibitor, Therapy, Treatment, Skidmore College. This article was prepared by Biotech ...
2009 NOV 23 ... Zagreb, Croatia. Keywords: City:Zagreb, Country:Croatia, Hypertension, Phosphodiesterase Inhibitor, Sildenafil, Vasodilator Agent. This article was prepared by Biotech ...
2009 NOV 23 ... tolerability, and efficacy of tadalafil, a selective, long acting, type V cyclic GMP phosphodiesterase (PDE-5) inhibitor, in this clinical syndrome," scientists writing in the Journal of ...
2009 NOV 16 ... Physiology, Caffeine, Central Nervous System Stimulant, Hypoglycemia, Metabolism, Phosphodiesterase Inhibitor, Therapy, Treatment, Northumbria University. This article was prepared by ...
2009 NOV 9 ... Fatigue Syndrome, Endocrine, Gastroenterology, Hepatology, Hormones, Liver Function, Phosphodiesterase Inhibitor, Virology This article was prepared by Pain & Central Nervous System Week ...